These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 12662146)
1. Anti-inflammatory strategies for the treatment of sepsis. Riedemann NC; Ward PA Expert Opin Biol Ther; 2003 Apr; 3(2):339-50. PubMed ID: 12662146 [TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory therapies in sepsis and septic shock. Freeman BD; Natanson C Expert Opin Investig Drugs; 2000 Jul; 9(7):1651-63. PubMed ID: 11060768 [TBL] [Abstract][Full Text] [Related]
3. Re-Evaluating Biologic Pharmacotherapies that Target the Host Response during Sepsis. Tuttle K; McDonald M; Anderson E Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801287 [TBL] [Abstract][Full Text] [Related]
4. Inflammation and coagulation: implications for the septic patient. Dellinger RP Clin Infect Dis; 2003 May; 36(10):1259-65. PubMed ID: 12746771 [TBL] [Abstract][Full Text] [Related]
5. The role of heparin and allied compounds in the treatment of sepsis. Cornet AD; Smit EG; Beishuizen A; Groeneveld AB Thromb Haemost; 2007 Sep; 98(3):579-86. PubMed ID: 17849046 [TBL] [Abstract][Full Text] [Related]
6. Recombinant anticoagulant factors for adjunctive treatment of sepsis. Levi M; Lowenberg E; Meijers JC Semin Thromb Hemost; 2010 Jul; 36(5):550-7. PubMed ID: 20632252 [TBL] [Abstract][Full Text] [Related]
7. [Activated protein C, coagulation, inflammation, and treatment of severe sepsis]. van Deventer SJ; Pajkrt D Ned Tijdschr Geneeskd; 2001 Mar; 145(13):613-6. PubMed ID: 11305209 [TBL] [Abstract][Full Text] [Related]
9. [Antithrombin III in the treatment of sepsis-- new approaches to prescribing the old drug]. Galstian GM; Shutova NA; Gorodetskiĭ VM Anesteziol Reanimatol; 2007; (6):66-71. PubMed ID: 18326265 [No Abstract] [Full Text] [Related]
10. [Activated protein C, a protein at the crossroads between coagulation and inflammation]. Borgel D; Vieillard-Baron A Med Sci (Paris); 2011 May; 27(5):501-7. PubMed ID: 21609671 [TBL] [Abstract][Full Text] [Related]
11. Drotrecogin alfa (activated): a novel therapeutic strategy for severe sepsis. Pastores SM Postgrad Med J; 2003 Jan; 79(927):5-10. PubMed ID: 12566544 [TBL] [Abstract][Full Text] [Related]
13. [Adjuvant treatment of sepsis: what is known?]. Wiedermann CJ Med Klin Intensivmed Notfmed; 2014 Nov; 109(8):583-90. PubMed ID: 25330980 [TBL] [Abstract][Full Text] [Related]
14. Maresins as novel anti-inflammatory actors and putative therapeutic targets in sepsis. Sun Y; Sun S; Chen P; Dai Y; Yang D; Lin Y; Yi L Pharmacol Res; 2024 Apr; 202():107113. PubMed ID: 38387744 [TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of sepsis. Jacobi J Am J Health Syst Pharm; 2002 Feb; 59 Suppl 1():S3-8. PubMed ID: 11885412 [TBL] [Abstract][Full Text] [Related]
16. New concepts in treatment of sepsis. le Roux P SADJ; 2004 Jun; 59(5):208-9. PubMed ID: 15449442 [TBL] [Abstract][Full Text] [Related]
17. Novel therapies for sepsis: a review. Deans KJ; Haley M; Natanson C; Eichacker PQ; Minneci PC J Trauma; 2005 Apr; 58(4):867-74. PubMed ID: 15824673 [TBL] [Abstract][Full Text] [Related]
19. New therapies for sepsis. Cunnington A; Nadel S Curr Top Med Chem; 2008; 8(7):603-14. PubMed ID: 18473886 [TBL] [Abstract][Full Text] [Related]
20. [Activated protein C, coagulation, inflammation and treatment of severe sepsis]. Bartelink AK; van Deuren M Ned Tijdschr Geneeskd; 2001 Jun; 145(24):1178-9. PubMed ID: 11433669 [No Abstract] [Full Text] [Related] [Next] [New Search]